OLEANZ 2.5 MG TAB

General Information
Brand Name: OLEANZ® 2.5
Generic Name: Olanzapine Tablets IP
Strength: 2.5 mg
Quantity: 10 tablets per blister strip
Dosage Form: Film-coated tablets
Product Type: Prescription pharmaceutical medicine
Route of Administration: Oral
Form Factor: Solid oral tablet
Maximum Shelf Life: Approximately 24 months from the date of manufacture (March 2025 to February 2027)
Food Preference: Not applicable. This is a medicinal product and not a food item.
FSSAI Information: Not applicable and not mentioned on the package, as FSSAI registration pertains to food products and certain nutraceuticals rather than prescription medicines.
Product Details and Ingredients
Each film-coated tablet contains:
Olanzapine IP – 2.5 mg
The formulation also contains pharmaceutical excipients in sufficient quantities required for tablet formulation and stability.
Colouring Agents
The tablet contains approved colouring agents, including:
Quinoline Yellow WS
Titanium Dioxide IP
These colouring agents contribute to the appearance and identification of the tablet while complying with pharmaceutical quality standards.
Directions for Use
OLEANZ® 2.5 should be used strictly according to the advice of a qualified healthcare professional.
The dosage instruction printed on the package states:
“As directed by the Psychiatrist.”
The tablet should be swallowed whole with water. It should not be crushed, broken, or chewed unless specifically instructed by a healthcare professional. The medicine should be taken in the prescribed dosage and for the duration recommended by the treating physician.
Product Description
OLEANZ® 2.5 is a pharmaceutical preparation containing Olanzapine, a prescription drug formulated as a film-coated tablet. The product is manufactured under stringent pharmaceutical quality standards and complies with Indian Pharmacopoeia specifications.

Each tablet delivers 2.5 mg of Olanzapine IP and is packed in a protective blister strip designed to safeguard the medicine from environmental exposure. The inclusion of approved excipients and colouring agents helps maintain product integrity, appearance, and stability throughout the product’s shelf life.

The blister pack prominently carries a Schedule H caution statement, emphasizing that the medicine should only be dispensed on the prescription of a qualified medical practitioner. Proper storage and handling are important to ensure that the medicine retains its quality until the expiry date.

The product is supplied in convenient strips of ten tablets and is intended for prescription-based therapeutic use under professional medical supervision.

Manufacturer Information
OLEANZ® 2.5 is manufactured in India by:
Sun Pharma Laboratories Ltd.
Plot No. 107–108, Namli Block
P.O. Ranipool
Gangtok, Sikkim – 737135
India
Manufacturing Licence Number: M/545/2014
Sun Pharma Laboratories Ltd. is responsible for the manufacturing of the product in accordance with applicable pharmaceutical manufacturing standards and regulatory requirements.